MediWound Ltd. (NASDAQ: MDWD) was upgraded by analysts at StockNews.com to a "sell" rating.
MediWound Ltd. (NASDAQ: MDWD) was upgraded by analysts at StockNews.com to a "sell" rating.
MediWound to Present New Data from EscharEx® Phase II Studies at Three Leading Wound Care Conferences [Yahoo! Finance]
MediWound to Present New Data from EscharEx® Phase II Studies at Three Leading Wound Care Conferences
MediWound Ltd. (NASDAQ: MDWD) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.